Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia

NCT05828108 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Steroid-refractory Diamond-Blackfan Anemia (DBA)

Interventions

DRUG: Bitopertin

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)